| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 3.46e-08 | 4 | 42 | 3 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 3.46e-08 | 4 | 42 | 3 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 8.63e-08 | 5 | 42 | 3 | GO:0047894 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.44e-07 | 26 | 42 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 3.01e-07 | 7 | 42 | 3 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 7.20e-07 | 9 | 42 | 3 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.03e-06 | 10 | 42 | 3 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 2.44e-06 | 13 | 42 | 3 | GO:0050656 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.25e-06 | 52 | 42 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | channel activity | 1.01e-04 | 525 | 42 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.03e-04 | 526 | 42 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 1.92e-04 | 10 | 42 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.10e-04 | 55 | 42 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 3.32e-04 | 13 | 42 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 3.32e-04 | 13 | 42 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.71e-04 | 459 | 42 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.51e-04 | 171 | 42 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 5.06e-04 | 74 | 42 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 9.35e-04 | 758 | 42 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.22e-03 | 793 | 42 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | cAMP binding | 1.26e-03 | 25 | 42 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.19e-03 | 33 | 42 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.30e-03 | 125 | 42 | 3 | GO:0015108 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.80e-03 | 465 | 42 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 3.05e-03 | 39 | 42 | 2 | GO:0030551 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor binding | 3.36e-03 | 41 | 42 | 2 | GO:0005154 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 3.69e-03 | 43 | 42 | 2 | GO:0043548 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 3.92e-03 | 151 | 42 | 3 | GO:0008509 | |
| GeneOntologyMolecularFunction | transporter activity | 4.86e-03 | 1289 | 42 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 5.16e-03 | 51 | 42 | 2 | GO:0001784 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 5.16e-03 | 51 | 42 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 5.19e-03 | 167 | 42 | 3 | GO:0015079 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.22e-03 | 334 | 42 | 4 | GO:0022836 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 5.55e-03 | 171 | 42 | 3 | GO:0015103 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.73e-03 | 343 | 42 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.74e-03 | 193 | 42 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.18e-03 | 197 | 42 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 9.27e-03 | 69 | 42 | 2 | GO:0045309 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 9.79e-03 | 627 | 42 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.08e-02 | 1180 | 42 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.23e-02 | 664 | 42 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.41e-02 | 86 | 42 | 2 | GO:0005254 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 8.42e-08 | 5 | 43 | 3 | GO:0018960 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 5.62e-06 | 17 | 43 | 3 | GO:0034035 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 5.62e-06 | 17 | 43 | 3 | GO:0050427 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 5.62e-06 | 17 | 43 | 3 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 6.74e-06 | 18 | 43 | 3 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 1.45e-05 | 23 | 43 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | sulfation | 2.38e-05 | 27 | 43 | 3 | GO:0051923 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 6.97e-05 | 106 | 43 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.28e-04 | 47 | 43 | 3 | GO:0046164 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.74e-04 | 52 | 43 | 3 | GO:0008210 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 1.84e-04 | 53 | 43 | 3 | GO:0071320 | |
| GeneOntologyBiologicalProcess | dopamine catabolic process | 1.89e-04 | 10 | 43 | 2 | GO:0042420 | |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | 2.29e-04 | 268 | 43 | 5 | GO:0045017 | |
| GeneOntologyBiologicalProcess | catecholamine catabolic process | 2.31e-04 | 11 | 43 | 2 | GO:0042424 | |
| GeneOntologyBiologicalProcess | catechol-containing compound catabolic process | 2.31e-04 | 11 | 43 | 2 | GO:0019614 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 3.26e-04 | 13 | 43 | 2 | GO:0009812 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 3.40e-04 | 160 | 43 | 4 | GO:0051384 | |
| GeneOntologyBiologicalProcess | phenol-containing compound catabolic process | 3.80e-04 | 14 | 43 | 2 | GO:0019336 | |
| GeneOntologyBiologicalProcess | positive regulation of heterotypic cell-cell adhesion | 4.38e-04 | 15 | 43 | 2 | GO:0034116 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 4.74e-04 | 73 | 43 | 3 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 4.93e-04 | 74 | 43 | 3 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 4.93e-04 | 74 | 43 | 3 | GO:0006584 | |
| GeneOntologyBiologicalProcess | oligosaccharide catabolic process | 5.00e-04 | 16 | 43 | 2 | GO:0009313 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 5.88e-04 | 185 | 43 | 4 | GO:0031960 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 7.88e-04 | 20 | 43 | 2 | GO:0042402 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 7.92e-04 | 87 | 43 | 3 | GO:0086001 | |
| GeneOntologyBiologicalProcess | action potential | 8.02e-04 | 201 | 43 | 4 | GO:0001508 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 9.11e-04 | 208 | 43 | 4 | GO:0035725 | |
| GeneOntologyBiologicalProcess | amine catabolic process | 9.55e-04 | 22 | 43 | 2 | GO:0009310 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 9.61e-04 | 93 | 43 | 3 | GO:0086003 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.06e-03 | 1017 | 43 | 8 | GO:0098660 | |
| GeneOntologyBiologicalProcess | response to cAMP | 1.09e-03 | 97 | 43 | 3 | GO:0051591 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.16e-03 | 222 | 43 | 4 | GO:0071466 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.40e-03 | 400 | 43 | 5 | GO:0006936 | |
| GeneOntologyBiologicalProcess | regulation of heterotypic cell-cell adhesion | 1.44e-03 | 27 | 43 | 2 | GO:0034114 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 1.60e-03 | 412 | 43 | 5 | GO:0006066 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.64e-03 | 112 | 43 | 3 | GO:1902476 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.68e-03 | 113 | 43 | 3 | GO:0051262 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | 1.80e-03 | 1374 | 43 | 9 | GO:0006811 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 1.90e-03 | 1115 | 43 | 8 | GO:0034220 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | 1.91e-03 | 429 | 43 | 5 | GO:0046486 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.05e-03 | 121 | 43 | 3 | GO:0051899 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 2.05e-03 | 121 | 43 | 3 | GO:0006576 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | 2.21e-03 | 1142 | 43 | 8 | GO:0019637 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.35e-03 | 127 | 43 | 3 | GO:0070252 | |
| GeneOntologyBiologicalProcess | chloride transport | 2.40e-03 | 128 | 43 | 3 | GO:0006821 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.54e-03 | 275 | 43 | 4 | GO:0006814 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.56e-03 | 36 | 43 | 2 | GO:0086010 | |
| GeneOntologyCellularComponent | HCN channel complex | 2.47e-05 | 4 | 43 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.51e-04 | 17 | 43 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | transporter complex | 8.60e-04 | 550 | 43 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.03e-03 | 378 | 43 | 5 | GO:0034702 | |
| GeneOntologyCellularComponent | cation channel complex | 1.36e-03 | 235 | 43 | 4 | GO:0034703 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.62e-03 | 29 | 43 | 2 | GO:0034706 | |
| Domain | Ion_trans_N | 2.95e-05 | 4 | 42 | 2 | PF08412 | |
| Domain | Ion_trans_N | 2.95e-05 | 4 | 42 | 2 | IPR013621 | |
| Domain | Sulfotransferase_dom | 7.17e-05 | 36 | 42 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 7.17e-05 | 36 | 42 | 3 | PF00685 | |
| Domain | Ion_trans_dom | 1.23e-04 | 114 | 42 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.23e-04 | 114 | 42 | 4 | PF00520 | |
| Domain | Na_channel_asu | 2.20e-04 | 10 | 42 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.20e-04 | 10 | 42 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.20e-04 | 10 | 42 | 2 | PF06512 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.42e-04 | 14 | 42 | 2 | IPR003938 | |
| Domain | cNMP-bd_CS | 5.81e-04 | 16 | 42 | 2 | IPR018488 | |
| Domain | CNMP_BINDING_1 | 2.35e-03 | 32 | 42 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.35e-03 | 32 | 42 | 2 | PS00889 | |
| Domain | cNMP | 2.65e-03 | 34 | 42 | 2 | SM00100 | |
| Domain | cNMP_binding | 2.65e-03 | 34 | 42 | 2 | PF00027 | |
| Domain | GPCR_2_secretin-like_CS | 2.65e-03 | 34 | 42 | 2 | IPR017983 | |
| Domain | cNMP-bd_dom | 2.80e-03 | 35 | 42 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 2.80e-03 | 35 | 42 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 3.30e-03 | 38 | 42 | 2 | IPR018490 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 3.65e-03 | 40 | 42 | 2 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 3.65e-03 | 40 | 42 | 2 | PS50227 | |
| Domain | GPCR_2_extracellular_dom | 3.65e-03 | 40 | 42 | 2 | IPR001879 | |
| Domain | - | 5.22e-03 | 48 | 42 | 2 | 2.60.120.10 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 5.65e-03 | 50 | 42 | 2 | PS00650 | |
| Domain | 7tm_2 | 5.65e-03 | 50 | 42 | 2 | PF00002 | |
| Domain | RmlC-like_jellyroll | 5.87e-03 | 51 | 42 | 2 | IPR014710 | |
| Domain | Glycoside_hydrolase_SF | 6.33e-03 | 53 | 42 | 2 | IPR017853 | |
| Domain | Channel_four-helix_dom | 7.29e-03 | 57 | 42 | 2 | IPR027359 | |
| Domain | - | 7.29e-03 | 57 | 42 | 2 | 1.20.120.350 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 8.67e-08 | 5 | 30 | 3 | M47807 | |
| Pathway | WP_RETINOL_METABOLISM | 2.13e-06 | 44 | 30 | 4 | MM15851 | |
| Pathway | KEGG_SULFUR_METABOLISM | 2.45e-06 | 13 | 30 | 3 | M18256 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.30e-05 | 22 | 30 | 3 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 1.50e-05 | 23 | 30 | 3 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 1.71e-05 | 24 | 30 | 3 | M16289 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.55e-05 | 39 | 30 | 3 | MM15695 | |
| Pathway | REACTOME_DRUG_ADME | 7.94e-05 | 109 | 30 | 4 | M45012 | |
| Pathway | REACTOME_DRUG_ADME | 1.12e-04 | 119 | 30 | 4 | MM15692 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 5.84e-04 | 17 | 30 | 2 | M39483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.32e-04 | 19 | 30 | 2 | M47733 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 8943792 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 7.04e-09 | 4 | 43 | 3 | 12390022 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 24318996 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 8424956 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 25370010 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 33414449 | ||
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 11389699 | ||
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 29908303 | ||
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 24802129 | ||
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 25053625 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 9370299 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 12438748 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 9.82e-08 | 8 | 43 | 3 | 10594240 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 9166597 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 1.47e-07 | 9 | 43 | 3 | 9060415 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 8887328 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 9177785 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 1.47e-07 | 9 | 43 | 3 | 23207770 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 8468045 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 19548878 | ||
| Pubmed | 2.10e-07 | 10 | 43 | 3 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 2.88e-07 | 11 | 43 | 3 | 7613026 | |
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 11154739 | ||
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 2.88e-07 | 11 | 43 | 3 | 9034160 | |
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 10720750 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.88e-07 | 11 | 43 | 3 | 8954725 | |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 3.84e-07 | 12 | 43 | 3 | 7706460 | |
| Pubmed | 4.99e-07 | 13 | 43 | 3 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 4.99e-07 | 13 | 43 | 3 | 17425406 | |
| Pubmed | 7.93e-07 | 15 | 43 | 3 | 1741163 | ||
| Pubmed | 1.42e-06 | 18 | 43 | 3 | 20056724 | ||
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 1.49e-06 | 2 | 43 | 2 | 8117269 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 19135060 | ||
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 1.49e-06 | 2 | 43 | 2 | 17548059 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 21456027 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 1.49e-06 | 2 | 43 | 2 | 11675786 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 31145702 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 10617600 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 10543947 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 29705271 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15752422 | ||
| Pubmed | 2.31e-06 | 21 | 43 | 3 | 32301970 | ||
| Pubmed | EP3 activation facilitates bladder excitability via HCN channels on ICCs. | 4.48e-06 | 3 | 43 | 2 | 28131828 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 33181864 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 8912648 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 7961757 | ||
| Pubmed | Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. | 4.48e-06 | 3 | 43 | 2 | 22652004 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 21187420 | ||
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 4.48e-06 | 3 | 43 | 2 | 8363592 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 21945247 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 22006928 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 9855620 | ||
| Pubmed | 6.67e-06 | 376 | 43 | 6 | 24154525 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 16043489 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 22748890 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 8.94e-06 | 4 | 43 | 2 | 9630217 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 9405696 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12928435 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 21615589 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 11525746 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 20140458 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 32152050 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 34429357 | ||
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 1.49e-05 | 5 | 43 | 2 | 15564593 | |
| Pubmed | Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. | 2.23e-05 | 6 | 43 | 2 | 15358107 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 25761792 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.67e-05 | 139 | 43 | 4 | 16985003 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 24136195 | ||
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 3.12e-05 | 7 | 43 | 2 | 19421833 | |
| Pubmed | 3.51e-05 | 149 | 43 | 4 | 25184681 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 21738584 | ||
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 24121790 | ||
| Pubmed | 6.68e-05 | 10 | 43 | 2 | 16382102 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 6.68e-05 | 10 | 43 | 2 | 11535246 | |
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 22683124 | ||
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 34368133 | ||
| Pubmed | The Tbx20-TLE interaction is essential for the maintenance of the second heart field. | 8.15e-05 | 11 | 43 | 2 | 37756602 | |
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 18473783 | ||
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 9269777 | ||
| Pubmed | Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. | 9.78e-05 | 12 | 43 | 2 | 17482496 | |
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 2759422 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 9.89e-05 | 72 | 43 | 3 | 8075499 | |
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 1.35e-04 | 14 | 43 | 2 | 29107716 | |
| Pubmed | 1.55e-04 | 15 | 43 | 2 | 31366290 | ||
| Pubmed | 1.55e-04 | 15 | 43 | 2 | 21147989 | ||
| Pubmed | 1.55e-04 | 15 | 43 | 2 | 23255421 | ||
| Pubmed | 2.26e-04 | 18 | 43 | 2 | 27180262 | ||
| Pubmed | 2.52e-04 | 19 | 43 | 2 | 20185795 | ||
| Pubmed | 2.80e-04 | 20 | 43 | 2 | 1370487 | ||
| Pubmed | 3.09e-04 | 21 | 43 | 2 | 30270038 | ||
| Pubmed | 4.05e-04 | 24 | 43 | 2 | 20624904 | ||
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 4.07e-04 | 282 | 43 | 4 | 35007762 | |
| Pubmed | 5.53e-04 | 28 | 43 | 2 | 18067320 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 6.25e-04 | 1201 | 43 | 7 | 35696571 | |
| Pubmed | Wnt/Ī²-catenin signaling maintains the mesenchymal precursor pool for murine sinus horn formation. | 6.79e-04 | 31 | 43 | 2 | 21757651 | |
| Pubmed | Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. | 6.79e-04 | 31 | 43 | 2 | 17473172 | |
| Pubmed | 7.23e-04 | 32 | 43 | 2 | 23986795 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 9.17e-04 | 925 | 43 | 6 | 28986522 | |
| Pubmed | 9.67e-04 | 37 | 43 | 2 | 16707424 | ||
| Interaction | SULT2B1 interactions | 7.80e-06 | 61 | 42 | 4 | int:SULT2B1 | |
| Interaction | SULT1C2 interactions | 7.97e-06 | 19 | 42 | 3 | int:SULT1C2 | |
| Interaction | SULT1A3 interactions | 1.65e-05 | 24 | 42 | 3 | int:SULT1A3 | |
| Cytoband | 12q23 | 1.28e-05 | 6 | 43 | 2 | 12q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 2.27e-03 | 278 | 43 | 3 | chr16p11 | |
| GeneFamily | Sulfotransferases, cytosolic | 8.42e-07 | 14 | 25 | 3 | 762 | |
| GeneFamily | Cyclic nucleotide gated channels | 8.20e-05 | 10 | 25 | 2 | 250 | |
| GeneFamily | SH2 domain containing | 8.53e-03 | 101 | 25 | 2 | 741 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.09e-02 | 115 | 25 | 2 | 769 | |
| Coexpression | LE_EGR2_TARGETS_DN | 1.21e-06 | 117 | 42 | 5 | MM1139 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 4.30e-06 | 68 | 42 | 4 | MM770 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 6.17e-06 | 444 | 42 | 7 | MM1051 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 7.56e-06 | 24 | 42 | 3 | MM1317 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 2.50e-05 | 5 | 42 | 2 | M41007 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 6.47e-05 | 135 | 42 | 4 | MM753 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 1.23e-04 | 490 | 42 | 6 | MM1001 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 1.24e-04 | 491 | 42 | 6 | MM455 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.54e-05 | 156 | 43 | 4 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.54e-05 | 156 | 43 | 4 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.54e-05 | 156 | 43 | 4 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.54e-05 | 156 | 43 | 4 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.48e-05 | 176 | 43 | 4 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 176 | 43 | 4 | 450c25ec5eeb65425f904e0a25aaafdf5682ef9c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 176 | 43 | 4 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 178 | 43 | 4 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-05 | 178 | 43 | 4 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-05 | 61 | 43 | 3 | 46cdf693c7f2df4fc43df7837b152871af67bef0 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-05 | 61 | 43 | 3 | c73fa489427a6e11badbdfc0324008137806ac7d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.82e-05 | 61 | 43 | 3 | c2c633f49f6ad8581c33794c909f40aa59f0b5c5 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.95e-05 | 184 | 43 | 4 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 186 | 43 | 4 | 6e6998f5ccb1b2628048a21e8d3053e020569aba | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.08e-05 | 186 | 43 | 4 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 187 | 43 | 4 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 187 | 43 | 4 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 187 | 43 | 4 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.41e-05 | 191 | 43 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 192 | 43 | 4 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 192 | 43 | 4 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 192 | 43 | 4 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.63e-05 | 194 | 43 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-05 | 194 | 43 | 4 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.77e-05 | 196 | 43 | 4 | 89a0ccd0684777927d99d5fc5b7c498f3f124250 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 3.77e-05 | 196 | 43 | 4 | 91a8c4798572d6c1f03cef5e8e5464ed0046c7cf | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.00e-05 | 199 | 43 | 4 | b65fbfed4a9938820cf900afd350b4ecb789b7b3 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.08e-05 | 200 | 43 | 4 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.08e-05 | 200 | 43 | 4 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.08e-05 | 200 | 43 | 4 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.83e-05 | 82 | 43 | 3 | 7f0ee8dafc37c3628506397f88fbb98fc6420bfb | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Crispld2_(Neuron.Gad1Gad2.Synpr-Crispld2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.83e-05 | 82 | 43 | 3 | c8242d273513e99107c154afb489980d11008555 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 107 | 43 | 3 | d446ffbe93cd49669f1cf91411aae07cc15d9e2a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 107 | 43 | 3 | 5c9e745d0b08a4aa1f3a93f9cc094fac57061a30 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.96e-04 | 117 | 43 | 3 | 0602bbad908cb28c5093b74d717da5f2af577943 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.33e-04 | 124 | 43 | 3 | 80526f503e1477b9455d10f27f7e6b56caea3a66 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.18e-04 | 138 | 43 | 3 | d3d16b043024914475a5e3db0803be0d4678c165 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue-5|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.18e-04 | 138 | 43 | 3 | d1efb4ef05aba89dd46ce698c5ce359fe8ab41c1 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.18e-04 | 138 | 43 | 3 | 3bb5d4c23335866d41e8e99db0676ee5799e5aff | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.18e-04 | 138 | 43 | 3 | c4f6381977d39ad3f7e1e1fa1217a802e8804132 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.46e-04 | 142 | 43 | 3 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-04 | 146 | 43 | 3 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | Lymphoid-Lymphoid-NK_cells|Lymphoid / shred on cell class and cell subclass (v4) | 3.91e-04 | 148 | 43 | 3 | d51a4b654a88d58dcdf29c2bc362c0cc1c40723a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.99e-04 | 149 | 43 | 3 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 151 | 43 | 3 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 151 | 43 | 3 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 151 | 43 | 3 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 4.31e-04 | 153 | 43 | 3 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.31e-04 | 153 | 43 | 3 | ac793f3176ac3c42c23e7dffc12dd1b057bae4ae | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.39e-04 | 154 | 43 | 3 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-04 | 155 | 43 | 3 | babcb9e548f04ace8157d506d27c5941c692c491 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.47e-04 | 155 | 43 | 3 | 8dab23aad905cc35a35643baa0554acb3f6fe6c8 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.47e-04 | 155 | 43 | 3 | 42533beaded07068f00540de704de07e4f19abcf | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 4.56e-04 | 156 | 43 | 3 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 4.56e-04 | 156 | 43 | 3 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-04 | 33 | 43 | 2 | 5ce59ecc7f8432b14dc6cb9af56e1bf080e7d61f | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-04 | 157 | 43 | 3 | 2c767c526abcc8adea6ec4eb2cc333060bb213b5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-04 | 157 | 43 | 3 | 3216063174d794ff25b6743b6432ae1a9207614d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-04 | 158 | 43 | 3 | 3d6295fe25e3b1fb4b6e83704c5bdbf86dc639b3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.73e-04 | 158 | 43 | 3 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 158 | 43 | 3 | 9f58428f70d1427b20122c5c1cc7bf521d0f4832 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.82e-04 | 159 | 43 | 3 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.91e-04 | 160 | 43 | 3 | 8308ca6f37986c526432a0fbc5f7ec2e75cfb6d7 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.91e-04 | 160 | 43 | 3 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | 939e25ef8b64242da2d28ef8342c8eb9cd199f17 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.91e-04 | 160 | 43 | 3 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-04 | 161 | 43 | 3 | 78cb72c462167021195917a06052bcdc367ad890 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.00e-04 | 161 | 43 | 3 | 0d05aa57312b095752fe13333b2def5f5b1cc83e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-C_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.00e-04 | 161 | 43 | 3 | 06e7becfd11d6ef1a45a9cfdfcb40b812600038e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-04 | 162 | 43 | 3 | dd4a08af653095ad4f63112312715589a1d43b38 | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 5.09e-04 | 162 | 43 | 3 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.09e-04 | 162 | 43 | 3 | fe546c2272a70bb5f08e6e097b9accdb891eda23 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.27e-04 | 164 | 43 | 3 | e5258efd6765acfc394708f697ec76acaef09079 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.27e-04 | 164 | 43 | 3 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | C_02|World / shred on cell type and cluster | 5.37e-04 | 165 | 43 | 3 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.46e-04 | 166 | 43 | 3 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 166 | 43 | 3 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 166 | 43 | 3 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 166 | 43 | 3 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-04 | 167 | 43 | 3 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-04 | 167 | 43 | 3 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 167 | 43 | 3 | 1a076a96d5d73d369453cd0dc8c81b70c1b824e7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-04 | 167 | 43 | 3 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.56e-04 | 167 | 43 | 3 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 167 | 43 | 3 | 89e3aab0d2359d2a44b50db328e7c542f73888ea | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 5.66e-04 | 168 | 43 | 3 | d02eba7ece17edcdd47fd6b784c93910ce61090f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-04 | 168 | 43 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-04 | 168 | 43 | 3 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-04 | 168 | 43 | 3 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-04 | 169 | 43 | 3 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-04 | 169 | 43 | 3 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-04 | 169 | 43 | 3 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-04 | 170 | 43 | 3 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-04 | 170 | 43 | 3 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-04 | 170 | 43 | 3 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.95e-04 | 171 | 43 | 3 | 4c36d0bf5fa3ddc2144f60769bb288ca4e4e20bc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-04 | 171 | 43 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 5.95e-04 | 171 | 43 | 3 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.95e-04 | 171 | 43 | 3 | c5c1d23b4040a78991512bfcbe046c51f202d2cf | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.16e-04 | 173 | 43 | 3 | e05cddf5bf63cf419343ff229453327519765be8 | |
| Drug | NDPS | 1.93e-08 | 45 | 42 | 5 | CID000090363 | |
| Drug | gallic acid | 6.93e-08 | 116 | 42 | 6 | CID000000370 | |
| Drug | dopamine-4-O-sulfate | 2.03e-07 | 7 | 42 | 3 | CID000123932 | |
| Drug | 2-naphthylsulfate | 2.03e-07 | 7 | 42 | 3 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 2.03e-07 | 7 | 42 | 3 | CID003035977 | |
| Drug | luciferyl sulfate | 2.03e-07 | 7 | 42 | 3 | CID011953812 | |
| Drug | 2-iodophenol | 3.25e-07 | 8 | 42 | 3 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 3.25e-07 | 8 | 42 | 3 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 3.25e-07 | 8 | 42 | 3 | CID003037707 | |
| Drug | 1IIg | 1.41e-06 | 45 | 42 | 4 | CID000001682 | |
| Drug | EM-139 | 1.65e-06 | 13 | 42 | 3 | CID000131427 | |
| Drug | naphthalenemethanol | 2.09e-06 | 14 | 42 | 3 | CID000020908 | |
| Drug | deoxoestrone | 2.09e-06 | 14 | 42 | 3 | CID000005888 | |
| Drug | arylsulfate | 2.62e-06 | 15 | 42 | 3 | CID000074426 | |
| Drug | cyclobenzaprine | 2.62e-06 | 15 | 42 | 3 | CID000002895 | |
| Drug | androstenediol | 2.96e-06 | 54 | 42 | 4 | CID000010634 | |
| Drug | A-44 | 3.21e-06 | 16 | 42 | 3 | CID000120353 | |
| Drug | benzilic acid | 3.90e-06 | 17 | 42 | 3 | CID000006463 | |
| Drug | AC1Q6OHG | 5.54e-06 | 19 | 42 | 3 | CID000115063 | |
| Drug | pedunculagin | 5.54e-06 | 19 | 42 | 3 | CID000442688 | |
| Drug | epicatechin-3-gallate | 6.24e-06 | 65 | 42 | 4 | CID000065056 | |
| Drug | PLP-Glu | 6.51e-06 | 20 | 42 | 3 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 7.59e-06 | 21 | 42 | 3 | CID000005895 | |
| Drug | MeA alpha C | 8.77e-06 | 22 | 42 | 3 | CID000062244 | |
| Drug | AABSSN | 8.77e-06 | 22 | 42 | 3 | CID005464134 | |
| Drug | taselin | 1.01e-05 | 23 | 42 | 3 | CID000023846 | |
| Drug | AalphaC | 1.15e-05 | 24 | 42 | 3 | CID000062805 | |
| Drug | AzMC | 1.31e-05 | 25 | 42 | 3 | CID000064986 | |
| Drug | minoxidil sulphate | 1.31e-05 | 25 | 42 | 3 | CID000004202 | |
| Drug | 2-pentanone | 1.31e-05 | 25 | 42 | 3 | CID000007895 | |
| Drug | alpha-methyldopamine | 1.47e-05 | 26 | 42 | 3 | CID000017005 | |
| Drug | glycolithocholic acid | 1.47e-05 | 26 | 42 | 3 | CID000115245 | |
| Drug | 1m2q | 1.47e-05 | 26 | 42 | 3 | CID005326637 | |
| Drug | Selenic Acid | 1.66e-05 | 27 | 42 | 3 | ctd:D064586 | |
| Drug | 4-nitrophenol | 1.81e-05 | 177 | 42 | 5 | CID000000980 | |
| Drug | Glu-P-2 | 2.06e-05 | 29 | 42 | 3 | CID000049970 | |
| Drug | hydroxyl radicals | MGAM PTPDC1 ALDH1A2 ATP8B4 FGG CALCRL LCK RRM1 CDC16 PCK1 CNOT8 | 2.23e-05 | 1341 | 42 | 11 | CID000000961 |
| Drug | 3,3'-T2 | 2.29e-05 | 30 | 42 | 3 | CID000065559 | |
| Drug | A2'p5'A2'p5'A | 2.53e-05 | 31 | 42 | 3 | CID000122642 | |
| Drug | acetaminophen sulfate | 2.53e-05 | 31 | 42 | 3 | CID000083939 | |
| Drug | barium hydroxide | 2.53e-05 | 31 | 42 | 3 | CID000028387 | |
| Drug | Ifosfamide [3778-73-2]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 3.02e-05 | 197 | 42 | 5 | 3485_UP | |
| Drug | DCNP | 3.06e-05 | 33 | 42 | 3 | CID000012066 | |
| Drug | A21250 | 4.18e-05 | 105 | 42 | 4 | CID000000990 | |
| Drug | mefenamic acid | 4.34e-05 | 37 | 42 | 3 | CID000004044 | |
| Drug | phenylhydroxylamine | 4.71e-05 | 38 | 42 | 3 | CID000007518 | |
| Drug | CHEMBL154623 | 4.71e-05 | 38 | 42 | 3 | CID010457096 | |
| Drug | d-equilenin | 5.93e-05 | 41 | 42 | 3 | CID000010597 | |
| Drug | L-alpha-methyldopa | 6.37e-05 | 42 | 42 | 3 | CID000004138 | |
| Drug | eg T | 6.37e-05 | 42 | 42 | 3 | CID000017284 | |
| Drug | Woodward's reagent K | 6.84e-05 | 43 | 42 | 3 | CID000077804 | |
| Drug | FSBA | 6.84e-05 | 43 | 42 | 3 | CID000133128 | |
| Drug | ND2001 | 6.94e-05 | 7 | 42 | 2 | CID000160207 | |
| Drug | Picolax | 6.94e-05 | 7 | 42 | 2 | CID000005243 | |
| Drug | Phosphoadenosine Phosphosulfate | 6.94e-05 | 7 | 42 | 2 | ctd:D010724 | |
| Drug | NSC674039 | 7.33e-05 | 44 | 42 | 3 | CID000001249 | |
| Drug | 4-octylphenol | 8.94e-05 | 47 | 42 | 3 | CID000015730 | |
| Drug | N-hydroxy-4-aminobiphenyl | 9.24e-05 | 8 | 42 | 2 | ctd:C014593 | |
| Drug | salicylamide | 9.53e-05 | 48 | 42 | 3 | CID000005147 | |
| Drug | sulfamethazine | 9.53e-05 | 48 | 42 | 3 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 9.53e-05 | 48 | 42 | 3 | CID000005896 | |
| Drug | tyramine | 9.60e-05 | 130 | 42 | 4 | CID000005610 | |
| Drug | EDTA | 1.11e-04 | 135 | 42 | 4 | CID000006049 | |
| Drug | 2-acetylaminofluorene | 1.17e-04 | 262 | 42 | 5 | CID000005897 | |
| Drug | cppc | 1.19e-04 | 9 | 42 | 2 | CID000016521 | |
| Drug | C12063 | 1.28e-04 | 429 | 42 | 6 | CID005282055 | |
| Drug | 9-hydroxybenzo(a)pyrene | 1.28e-04 | 53 | 42 | 3 | CID000028598 | |
| Drug | acetaminophen | 1.34e-04 | 270 | 42 | 5 | CID000001983 | |
| Drug | minoxidil | 1.36e-04 | 54 | 42 | 3 | CID000004201 | |
| Drug | MeIQx | 1.43e-04 | 55 | 42 | 3 | CID000062275 | |
| Drug | diopside | 1.48e-04 | 10 | 42 | 2 | CID000166740 | |
| Drug | Antarcticite | 1.51e-04 | 56 | 42 | 3 | CID000024486 | |
| Drug | NSC36919 | 1.68e-04 | 58 | 42 | 3 | CID000235496 | |
| Drug | 4-hydroxyestrone | 1.77e-04 | 59 | 42 | 3 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.77e-04 | 59 | 42 | 3 | CID000083944 | |
| Drug | NaOH | 2.05e-04 | 62 | 42 | 3 | CID000014798 | |
| Drug | 3-OHBaP | 2.15e-04 | 63 | 42 | 3 | CID000025890 | |
| Drug | 1,4-dichlorobut-2-ene | 2.17e-04 | 12 | 42 | 2 | CID000015122 | |
| Drug | 4-nonylphenol | 2.25e-04 | 64 | 42 | 3 | CID000001752 | |
| Drug | bi-5 | 2.56e-04 | 13 | 42 | 2 | CID002352168 | |
| Drug | colestimide | 2.56e-04 | 13 | 42 | 2 | CID000065840 | |
| Drug | cast 3 | 2.56e-04 | 13 | 42 | 2 | CID000072360 | |
| Drug | galloylglucose | 2.56e-04 | 13 | 42 | 2 | CID000124375 | |
| Drug | mannostatin A | 2.56e-04 | 13 | 42 | 2 | CID000124189 | |
| Drug | magnesium citrate | 2.98e-04 | 14 | 42 | 2 | CID000008949 | |
| Drug | Pyrethroids | 3.06e-04 | 71 | 42 | 3 | CID000005053 | |
| Drug | adenylylsulfate | 3.19e-04 | 72 | 42 | 3 | CID000000228 | |
| Drug | lanthanum fluoride | 3.44e-04 | 15 | 42 | 2 | CID000083675 | |
| Drug | F1-4 | 3.44e-04 | 15 | 42 | 2 | CID000006393 | |
| Drug | aspartate | 3.53e-04 | 518 | 42 | 6 | CID000000424 | |
| Drug | 7-hydroxycoumarin | 3.59e-04 | 75 | 42 | 3 | CID005281426 | |
| Drug | o-CP | 4.03e-04 | 78 | 42 | 3 | CID000445454 | |
| Drug | benzyloxyresorufin | 4.03e-04 | 78 | 42 | 3 | CID000114982 | |
| Drug | 4-hydroxyestradiol | 4.19e-04 | 79 | 42 | 3 | CID000001743 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.35e-04 | 193 | 42 | 4 | 6205_DN | |
| Drug | fagomine | 4.44e-04 | 17 | 42 | 2 | CID000072259 | |
| Drug | zatebradine | 4.44e-04 | 17 | 42 | 2 | CID000065637 | |
| Drug | reverse T3 | 4.67e-04 | 82 | 42 | 3 | CID000022069 | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 4.98e-04 | 200 | 42 | 4 | 5494_UP | |
| Drug | pyrrolidinium | 5.19e-04 | 85 | 42 | 3 | CID000031268 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 5.65e-06 | 3 | 41 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 8.42e-05 | 10 | 41 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 8.42e-05 | 10 | 41 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.23e-04 | 12 | 41 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Tremor, Rubral | 2.23e-04 | 16 | 41 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 2.23e-04 | 16 | 41 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 2.23e-04 | 16 | 41 | 2 | C0278161 | |
| Disease | Abnormal coordination | 2.23e-04 | 16 | 41 | 2 | C0520966 | |
| Disease | amyloid-beta measurement, Alzheimer's disease biomarker measurement | 2.23e-04 | 16 | 41 | 2 | EFO_0005194, EFO_0006514 | |
| Disease | Ataxia, Truncal | 2.23e-04 | 16 | 41 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 2.23e-04 | 16 | 41 | 2 | C0240991 | |
| Disease | QRS-T angle | 4.35e-04 | 106 | 41 | 3 | EFO_0020097 | |
| Disease | Epilepsy | 4.72e-04 | 109 | 41 | 3 | C0014544 | |
| Disease | Ataxia | 5.54e-04 | 25 | 41 | 2 | C0004134 | |
| Disease | brain infarction (biomarker_via_orthology) | 9.68e-04 | 33 | 41 | 2 | DOID:3454 (biomarker_via_orthology) | |
| Disease | mitochondrial DNA measurement | 1.10e-03 | 328 | 41 | 4 | EFO_0006312 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.22e-03 | 37 | 41 | 2 | EFO_0022281 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 1.35e-03 | 39 | 41 | 2 | EFO_0022332 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MYWYNFLAYHMASAK | 481 | O14727 | |
| KHRYYYGMGWGFPLL | 671 | Q6QNK2 | |
| FLGVDFGYYWFHRMA | 121 | Q6ZNB7 | |
| TFRYYAGWADKIHGM | 146 | O94788 | |
| LGHSYFINWDRKMYY | 351 | Q8TF62 | |
| MSWQQHYYGGSAAKF | 6 | Q8NB25 | |
| GKHFWSFQMYGEDFV | 256 | Q8TBG4 | |
| FGVKIAMYFAWLGFY | 241 | Q9HCE9 | |
| FGYNFGKYLAHWLSM | 486 | P35558 | |
| LWYYGEHLFMLHGKS | 311 | Q9H8H0 | |
| WGKQYDIHNLYGYSM | 576 | O43451 | |
| YGSYSYMWSFEKAHL | 241 | Q5T0W9 | |
| FGEVWMGYYNGHTKV | 256 | P06239 | |
| SYFLPYWLFGSQMGK | 26 | Q86WI0 | |
| AFMEAGIYFYNFGWK | 146 | A2A3K4 | |
| DMGGLKLAYHAYQKW | 676 | O95672 | |
| WGKQYSYALFKAMSH | 461 | Q9Y3Q4 | |
| MAWTHDGKGMFYNSY | 176 | P48147 | |
| WMNKCHAGHLNGVYY | 361 | P02679 | |
| SWFAVGCYYLMVGHK | 301 | Q13042 | |
| WGKQYSYALFKAMSH | 341 | O60741 | |
| LEYGGKWKMLHYFAQ | 671 | O00462 | |
| VKWLSFHSGYDFGYM | 151 | Q9UFF9 | |
| FAEKQHLMWYYFLGW | 246 | Q16602 | |
| GAICKHLSWSAYMYY | 1641 | O75691 | |
| FQLGFMYYSGSGIWK | 411 | Q5TEA6 | |
| HGYFKYMSAVCWLFG | 186 | Q9HAT2 | |
| KFMAGEVSYGSWYQH | 161 | P0DMN0 | |
| KFMAGEVSYGSWYQH | 161 | P0DMM9 | |
| FKYYHWALSFLGMSL | 611 | Q9UP95 | |
| GWNWMYLYKLAFAQH | 226 | Q96S66 | |
| NYGKLTSMHFYGWKQ | 716 | P23921 | |
| SAKYFFKMAFYNGWI | 31 | Q99943 | |
| AAFFGLLGYSLYWMG | 336 | Q9H4I3 | |
| KFMAGEVSYGSWYQH | 161 | P50226 | |
| LKMFALRHYYFTIGW | 1571 | Q9UQD0 | |
| WFDNEAHGGLYGIYM | 3451 | Q86WI1 | |
| MALHFFFLVKDYGSW | 871 | O95427 | |
| FISGKFYWEFNMGHS | 336 | A0A3B3IT33 | |
| AMKFAFGEFHLWYQV | 406 | Q9ULT0 | |
| KWMAYGFKAYFSNGW | 986 | Q01118 | |
| HGKMWSYGFYLIHLQ | 471 | P52735 | |
| LGWHHFTMYFFFGLL | 91 | Q9NWC5 | |
| RKMAFDYYPFHWAGD | 361 | Q6BDS2 |